| Submission declined on 9 August 2024 by AirshipJungleman29 (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 4 July 2024 by Jamiebuba (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by Jamiebuba 40 days ago. | |
Yaw Bediako, PhD is a Ghanaian immunologist and co-founder and CEO[1] of Yemaachi Biotech, a biotech company based in Accra, Ghana building a cancer bio-database to incorporate African health data into R&D for cancer therapeutics.[1]
Bediako is a specialist in cellular and molecular immunology, with a focus on understanding immune function concerning both infectious and non-communicable diseases, such as cancer,[2] within African populations. He is credited with the development and implementation of the first national SARS-CoV-2 variant tracker on the continent, providing real-time visualization of viral variant distribution.[3][4]
Bediako has a PhD in Immunology from Northwestern University, Chicago, IL, and subsequently undertook post-doctoral fellowships at the KEMRI-Wellcome Trust Programme[5] in Kenya and at the Francis Crick Institute in London. He served on the faculty at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) at the University of Ghana.[4]
In November 2021, Yaw was selected as a Calestous Juma Science Leadership[6] Fellow by the Bill and Melinda Gates Foundation. Yaw is also a fellow of the Ghana Young Academy and an Affiliate member of the African Academy of Sciences[7]. In January of 2023, he was selected as one of the 100 most influential Africans by the New African magazine.[8]
Early Life and Education
editYaw grew up in Accra, Ghana.[9] He obtained his undergraduate degree at Calvin College in Grand Rapids, USA,[10] where he studied Biology/Biochemistry. After receiving his Ph.D. at Northwestern University, Bediako pursued a post-doctoral fellowship at the KEMRI – Wellcome Trust Research Programme in Kilifi, Kenya. He then focused on Malaria Immunology, before shifting his focus to cancer immunology.
Research Career
editAfter completing his PhD, Yaw worked as a post-doctoral researcher at the KEMRI-Wellcome[5] Trust Research Programme (Kilifi, Kenya) from 2013-2015.He then took up a second post-doctoral fellowship at the Francis Crick Institute (London, UK) where he worked from 2015-2019.[11] In 2019 Yaw took up a faculty position at the West African Centre for Cell Biology of Infectious Pathogens- University of Ghana.[12] In 2020, Yaw co-founded Yemaachi Biotech[13] and has served as Chief Executive Officer since then.[1]
Awards and Honours
editPublications
edit- Repeated clinical malaria episodes are associated with modification of the immune system in children. Y Bediako, R Adams, AJ Reid, JJ Valletta, FM Ndungu- BMC medicine, 2019 - Springer[16]
- Recommendations for empowering early career researchers to improve research culture and practice, A Antonietti, JM Azam, H Ballhausen, Y Bediako - PLoS, 2022 - journals.plos.org[17]
- Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana. E Obodai, ID Otchere, Y Bediako - Experimental , 2021 - journals.sagepub.com[18]
- Radiologic patterns of distant organ metastasis in advanced breast cancer patients: Prospective review of computed tomography images. AK Offei, D Hutchful, J Ngoi, Y Bediako - Cancer, 2024 - Wiley Online Library[19]
- Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria. Y Aniweh, GA Awandare, PK Quashie, Y Bediako - Cell Reports, 2024 - cell.com[20]
References
edit- ^ a b c AGBETILOYE, ADEKUNLE (7 March 2024). "Ghana's Yemaachi Biotech and global team SAMBAI secures $25 million Cancer Grand Challenges award".
- ^ Hove, Mike (25 May 2022). "Ghana Startup Vows to Change Global Cancer Research".
- ^ "Investigating the Immune Kinetics of COVID-19 Vaccine Responses Between European and African Populations". gcgh.grandchallenges.org. Retrieved 2024-08-09.
- ^ a b "Covid-19: As many as 1.2 million may have been affected in Accra – Dr. Yaw Bediako (2-11-20)". November 2, 2020.
- ^ a b "Yaw BEDIAKO". ICGEB. 2022-05-01. Retrieved 2024-08-09.
- ^ a b "Yaw Bediako". gcgh.grandchallenges.org. Retrieved 2024-08-09.
- ^ "Ghanaian Yaw Bediako fights cancer with technology". 19 April 2022.
- ^ a b "100 Most Influential Africans". newafricanmagazine.com. Retrieved 2024-08-09.
- ^ "The Ghanaian researcher who came home". Bill & Melinda Gates Foundation. Retrieved 2024-08-09.
- ^ "Yaw Bediako". gcgh.grandchallenges.org. Retrieved 2024-08-09.
- ^ "African Academy of Sciences welcomes Crick African Network fellows". Crick. Retrieved 2024-03-19.
- ^ Admin, WACCBIP. "Yaw Bediako - West African Centre for Cell Biology of Infectious Pathogens". www.waccbip.org. Retrieved 2024-03-19.
- ^ "Quest for Research Freedom Fuels African Biotech Boom". 1 June 2021.
- ^ "Under 40 young entrepreneurs, business leaders recognised". 4 October 2022.
- ^ "African Academy of Sciences welcomes Crick African Network fellows". Crick. 2024-07-09. Retrieved 2024-08-09.
- ^ Bediako, Yaw; Adams, Rhys; Reid, Adam J.; Valletta, John Joseph; Ndungu, Francis M.; Sodenkamp, Jan; Mwacharo, Jedidah; Ngoi, Joyce Mwongeli; Kimani, Domtila; Kai, Oscar; Wambua, Juliana; Nyangweso, George; de Villiers, Etienne P.; Sanders, Mandy; Lotkowska, Magda Ewa (2019-03-13). "Repeated clinical malaria episodes are associated with modification of the immune system in children". BMC Medicine. 17 (1): 60. doi:10.1186/s12916-019-1292-y. ISSN 1741-7015. PMC 6415347. PMID 30862316.
- ^ Kent, Brianne A.; Holman, Constance; Amoako, Emmanuella; Antonietti, Alberto; Azam, James M.; Ballhausen, Hanne; Bediako, Yaw; Belasen, Anat M.; Carneiro, Clarissa F. D.; Chen, Yen-Chung; Compeer, Ewoud B.; Connor, Chelsea A. C.; Crüwell, Sophia; Debat, Humberto; Dorris, Emma (2022-07-07). "Recommendations for empowering early career researchers to improve research culture and practice". PLOS Biology. 20 (7): e3001680. doi:10.1371/journal.pbio.3001680. ISSN 1545-7885. PMC 9295962. PMID 35797414.
- ^ Ngoi, Joyce M; Quashie, Peter K; Morang'a, Collins M; Bonney, Joseph HK; Amuzu, Dominic SY; Kumordjie, Selassie; Asante, Ivy A; Bonney, Evelyn Y; Eshun, Miriam; Boatemaa, Linda; Magnusen, Vanessa; Kotey, Erasmus N; Ndam, Nicaise T; Tei-Maya, Frederick; Arjarquah, Augustina K (16 December 2020). "Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana". Experimental Biology and Medicine. 246 (8): 960–970. doi:10.1177/1535370220975351. ISSN 1535-3702. PMC 7746953. PMID 33325750.
- ^ Jimah, Bashiru Babatunde; Amoako, Emmanuella; Ofori, Emmanuel Owusu; Akakpo, Patrick Kafui; Aniakwo, Luke Adagrah; Ulzen-Appiah, Kofi; Imbeah, Emmanuel Gustav; Morna, Martin Tangnaa; Koggoh, Patience; Akligoh, Harry; Tackie, Randy; Manu, Aida; Paemka, Lily; Sarkodie, Benjamin Dabo; Offei, Asare Kweku (13 February 2024). "Radiologic patterns of distant organ metastasis in advanced breast cancer patients: Prospective review of computed tomography images". Cancer Reports. 7 (2): e1988. doi:10.1002/cnr2.1988. ISSN 2573-8348. PMC 10864737. PMID 38351553.
- ^ "Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria". 50 Cell Reports. 24 July 2024.